Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Studies from James Cook University, Center for Cancer Research yield new information about cancer gene therapy
March 18th, 2008
Data detailed in 'Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer' have been presented. According to recent research from Townsville, Australia, "Human telomerase reverse transcriptase (hTERT) is believed to a reliable marker for telomerase activity. The expression of telomerase activity has not been investigated in a consecutive series of patients with colorectal adenocarcinoma in North Queensland." "The objective of this study was to evaluate the significance of hTERT mRNA expression in colorectal adenocarcinoma in North Queensland. Matched samples of tumor and adjacent non-tumorous mucosa samples from 53 colorectal...
Source: Cancer Weekly (2008-03-18)
|
